Stéphane MADDENS
Founder / CEO
VETBIOBANK
Lyon, France
About me
Founder of Vetbiobank - passionate about developing cell therapy as a new way to tackle complex diseases. I see veterinary medicine as a window over human health, our animals and us are sharing so much physiopathological processes.
Previously i was largely involved in R&D and clinical research program in human health related to cell, tissue transplantation, in oncology-oncohaematology and regenerative medicine - at the French Blood Transfusion institute, Hospitals, and also at Vertex Pharmaceuticals.
My organisation
Vetbiobank is a clinical stage biotech specialised in developing and manufacturing GMP cell therapy products for the veterinary market. Our lead drug-candidate targets canine osteoarthritis and is currently under review by EMA for market authorisation. We are also exploring exosomes/microvesicles from mesenchymal strom cells. Open for investments.
Speaker sessions (1)
Friday, 11 October 2024
14:00 - 15:00